Comparison Between Whole-Body MRI and PET/CT in Pediatric Oncology

1. Antoch G., Vogt FM., Freudenberg LS. et al. Wholebody dual-modality PET/CT and whole-body MRI for tumor staging in oncology // JAMA, 2003; 290:3199–206Search in Google Scholar

2. Brennan D. D., Gleeson T, Coate LE, et al. A comparison of whole-body MRI and CT for the staging of lymphoma //AJR Am J Roentgenlogy, 2005;185(3):711—6Search in Google Scholar

3. Canale S., Vilcot L., Ammari S. et al. Whole body MRI in pediatric oncology // Diagnostic and Interventional Imaging, 2014; 95, 541—55010.1016/j.diii.2013.11.00224704147Search in Google Scholar

4. Chawla S. C., et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review // Pediatric Radiology, 2010 May; 40(5): 681–68610.1007/s00247-009-1434-z284716319967534Search in Google Scholar

5. Chen Z., Li X., Fang Li, et al. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics // European Journal of Radiology, 2010; 75: 329–335Search in Google Scholar

6. Ciliberto M. et al. Comparison between wholebody MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review // Radiology and Oncology, 2013 Sep; 47(3): 206–21810.2478/raon-2013-0007379487524133384Search in Google Scholar

7. CureSearch for childrens cancer – [viewed 28.12.2016.]. Accessed: http://curesearch.org/Search in Google Scholar

8. ESMO 2016 Press Release: High response rate in phase I/II paediatric brain cancer trial sets stage for combination therapy with higher response and lower toxicity. October, 2016 – [viewed 06.03.2017.]. Accessed: http://www.esmo.org/Conferences/ESMO-2016-Congress/Press-Media/High-response-rate-in-phase-I-II-paediatric-brain-cancer-trial-sets-stage-for-combination-therapy-with-higher-response-and-lower-toxicitySearch in Google Scholar

9. Heindel W., Gübitz R., Vieth V., et al. The Diagnostic Imaging of Bone Metastases // Deutsches Ärzteblatt International, 2014;111(44):741-747Search in Google Scholar

10. Klenk C., Gawande R., Uslu L. et al. Ionising radiation-free whole-body MRI versus 18F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, nonrandomised, single-centre study // Lancet Oncology, 2014; 15: 275–85Search in Google Scholar

11. Krohmer S., Sorge I., Krausse A. et al. Whole-body MRI for primary evaluation of malignant disease in children // European Journal of Radiology, 2010; 74: 256–261Search in Google Scholar

12. Kumar J., Seith A., Kumar A., et al. Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT //Pediatric Radiology, 2008;38(9):953—62Search in Google Scholar

13. Punwani S., Taylor SA., Bainbridge A., et al. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging withan enhanced PET/CT reference for initial staging // Radiology, 2010;255(1):182—90Search in Google Scholar

14. Robbins E. Radiation risks from imaging studies in children with cancer // Pediatric Blood Cancer, 2008; 51: 453–57Search in Google Scholar

15. Schmidt GP, Baur-Melnyk A, Herzog P, et al. Highresolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomographycomputed tomography: experience on a 32-channel system // Investigative Radiology, 2005;40:743–53Search in Google Scholar

16. Vandevoorde C. CT Protocols and CT Dose Contribution in PET/CT // iPET 2011 – Parallel Session IIIc, Panel Discussion: Practical Aspects of CTSearch in Google Scholar